New Delhi [India], January 12 (ANI): Union Health Secretary Rajesh Bhushan on Tuesday said the COVID-19 vaccine may cost in the range of Rs 200 to 295 in India and two vaccines -- Covishield and Covaxin -- have received Emergency Use Authorisation (EAU) after going through established saf
New Delhi [India], January 5 (ANI): Union Health Secretary Rajesh Bhushan on Tuesday said the Centre has not banned the export of any COVID-19 vaccine.
New Delhi [India], January 5 (ANI): Days after Drugs Controller General of India (DCGI) gave approval to two COVID-19 vaccines, Union Health Secretary Rajesh Bhushan on Tuesday said that India is prepared to roll out vaccine within 10 days of emergency use authorisation (EUA), subject to
New Delhi [India], January 5 (ANI): India's active COVID-19 cases are less than 2.5 lakhs and are continuing to fall which has led to a decline in the overall burden on the health delivery structure, said Union Health Secretary Rajesh Bhushan on Tuesday.
New Delhi [India], December 29 (ANI): Five per cent of the coronavirus positive samples in the country would be subjected to genome sequencing, the government has said.
New Delhi [India], December 29 (ANI): The government will increase the number of genome sequencing for COVID-19 in view of the new coronavirus strain that was first detected in the United Kingdom, Union Health Secretary Rajesh Bhushan said on Tuesday.
New Delhi [India], December 15 (ANI): Informing that the Drugs Controller General of India has granted clearance for the clinical trials of one more candidate vaccine from India, NITI Aayog Member (Health) Dr VK Paul on Tuesday said six vaccines are currently undergoing clinical trials in
New Delhi [India], December 8 (ANI): Union Health Secretary Rajesh Bhushan on Tuesday said that the Centre had in August this year constituted the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC), which is providing guidance on prioritisation of population groups, procur
New Delhi [India], December 8 (ANI): Union Health Secretary Rajesh Bhushan on Tuesday said that there are six COVID-19 vaccine candidates in different clinical trial stages being developed by various manufacturers in India.
New Delhi [India], December 2 (ANI): Health Secretary Rajesh Bhushan said on Tuesday that "adverse event" related to vaccine trial participant in Chennai will not affect the timelines and noted that a trial site has an institutional ethics committee which is independent of the manufacture
New Delhi [India], December 1 (ANI): India recorded 211 COVID-19 cases per million population over the last seven days, which is lowest among big nations, Health Secretary Rajesh Bhushan said on Tuesday.
New Delhi [India], December 1 (ANI): The Union Health Ministry on Tuesday said that the government had never spoken about vaccinating the entire country for the coronavirus pandemic. At a press briefing, Union health secretary Rajesh Bhushan said that there might not even be a need to vac